Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
221.1 USD | +1.00% | +2.26% | -14.59% |
02:28pm | Redburn Atlantic Adjusts Price Target on Biogen to $235 From $275, Keeps Neutral Rating | MT |
May. 07 | FDA Sets June 10 Advisory Panel Meeting on Eli Lilly Alzheimer's Drug | DJ |
- Stock Market
- Equities
- BIIB Stock
- News Biogen Inc.